|
Market Closed -
Toronto S.E.
20:10:09 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.4050 CAD | -1.22% |
|
-8.99% | -10.99% |
| 08-27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 08-20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 40.5x | - | 1.52x | 18.99x | 44.54x | 50.33M | |
| -.--% | -.--% | 16.52x | 1.49x | 0.66x | 9.83x | 10.7x | 14.75B | |
| 2.28% | 2.61% | 16.37x | 1.69x | 0.73x | 7.65x | 9.59x | 6.34B | |
| 1.05% | 1.4% | 20.11x | 2.25x | 0.77x | 12.94x | 13.18x | 6.31B | |
| 2.88% | 3.29% | 14.67x | 2.17x | 0.9x | 6.29x | 8.42x | 4.12B | |
| 5.7% | 6.26% | 14.19x | 4.28x | 1.22x | 7.46x | 13.93x | 3.14B | |
| 5.12% | 5.67% | 14.1x | 2.67x | 0.6x | 4.6x | 7.57x | 3.12B | |
| 4.58% | 5.03% | 14.17x | 6.36x | 0.85x | 6.37x | 8.86x | 2.93B | |
| 0.02% | -.--% | -125.69x | 2.61x | 0.43x | 15.54x | 56.02x | 1.44B | |
| 2.12% | 2.52% | 19.12x | 3.35x | 0.57x | 7.27x | 11.89x | 1.41B | |
| 3.33% | 4.54% | 13.81x | 0.84x | 0.28x | 2.66x | 6.81x | 929M | |
| 6.28% | 5.49% | 19.67x | 2.31x | 0.81x | 7.45x | 17.72x | 843M | |
| 1.25% | 1.81% | 28.62x | 7.8x | 1.04x | 14.12x | 21.88x | 844M | |
| Average | 2.88% | 3.22% | 8.17x | 3.15x | 0.80x | 9.32x | 17.78x | 3.56B | |
| Weighted average by Cap. | 2.01% | 2.27% | 12.26x | 2.47x | 0.74x | 8.91x | 12.31x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
